Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A one year follow-up of JCV serology with index values in a French natalizumab treated multiple sclerosis cohort
Multiple Sclerosis
(-)
140
Authors/Disclosures
Olivier Outteryck
PRESENTER
Olivier Outteryck has nothing to disclose.
Gerhard Winkler, MD No disclosure on file
No disclosure on file
Arnaud Kwiatkowski (Hopital Saint Philibert) Arnaud Kwiatkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Arnaud Kwiatkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Arnaud Kwiatkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Arnaud Kwiatkowski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Arnaud Kwiatkowski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen .
Albert Verier, MD (Centre Hospitalier) No disclosure on file
Didier Ferriby, MD (Clinique Neurologique/Neuro D) No disclosure on file
No disclosure on file
Philippe Devos No disclosure on file
No disclosure on file
No disclosure on file
Patrick Hautecoeur (Centre Hospitalier Saint Philibert) No disclosure on file
Patrick Vermersch (CHR de Lille) Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.